MedPath

A randomized, placebo controlled trial comparing the efficacy of a combination of oral 5mg finasteride and 5% minoxidil solution versus 5%minoxidil alone in treatment of female pattern hair loss (FPHL) in post- menopausal women.

Phase 2
Conditions
female pattern hair loss
Androgenetic alopecia
Female pattern hair loss
Finasteride
Post&#45
menopausal women
Registration Number
TCTR20170919003
Lead Sponsor
none
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending (Not yet recruiting)
Sex
Female
Target Recruitment
40
Inclusion Criteria

Female age 18-60
Menopause
History, clinical and dermoscope showed Ludwig classification I-4,II-1,II-2,frontal type

Exclusion Criteria

family history of breast cancer, thyroid disease, iron deficiency anemia, pregnancy, psychiatric problem, previous treatment with laser or medication within 3 months. previous hair transplant within 1 year

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
hair density at 24 weeks after start intervention hair density(non-vellus hair) at midscalp by Fotofinder®
Secondary Outcome Measures
NameTimeMethod
photographic assessment score at 24 weeks after start intervention photographic assessment questionaire,hair mass index at midscalp at start and 24 weeks after start intervention HairCheck® ,severity of female androgenetic alopecia at start and 24 weeks after start intervention Ludwig classification ,Satisfaction score at start and 24 weeks after start intervention patient self-assessment questionnaires,side effect 4 weeks after start intervention questionare
© Copyright 2025. All Rights Reserved by MedPath